COMT and breast cancer: Compared with healthy controls, breast cancer patients receiving chemotherapy had slower treatment speed and poorer executive function, while apolipoprotein E (APOE) and COMT gene polymorphisms were associated with cognitive impairment (52).Our previous research findings indicated that COMT (rs165599) was a risk-related genetic factor influencing CRCI in TNBC patients (23).